Molecular effects of 2′,2′-difluorodeoxycytidine (gemcitabine) on DNA replication in intact HL-60 cells
Authors:
- Dennis P. CuddyDCDennis P. Cuddy
- 1 October 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 48 (8) , 1619-1630
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-?-d-arabinofuranosylcytosineCancer Chemotherapy and Pharmacology, 1992
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Cytotoxicity and Antitumor Activity of 2′,2′-Difluorodeoxycytidine (Gemcitabine)Cancer Investigation, 1990
- 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia CellsNucleosides, Nucleotides & Nucleic Acids, 1989
- Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosidesThe Journal of Organic Chemistry, 1988
- Deoxyribonucleoside triphosphate pools in human diploid fibroblasts and their modulation by hydroxyurea and deoxynucleosidesBiochemical Pharmacology, 1984
- Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluationCanadian Journal of Biochemistry, 1981
- Isolation and purification of large quantities of DNA replication intermediates by pH step alkaline elutionChromosoma, 1979
- Effect of cytosine arabinoside 5′-triphosphate on mammalian DNA polymeraseBiochemical and Biophysical Research Communications, 1969
- A proposed mechanism of action of 1-β-d-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cellsBiochemical Pharmacology, 1962